Currently, Procept BioRobotics Corp [PRCT] is trading at $91.00, up 32.33%. An important factor to consider is whether the stock is rising or falling in short-term value. The PRCT shares have gain 33.43% over the last week, with a monthly amount glided 14.42%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on August 11, 2023, when Piper Sandler initiated its Overweight rating and assigned the stock a price target of $42. On October 31, 2022, BTIG Research initiated with a Neutral rating. Truist started tracking the stock assigning a Buy rating and suggested a price target of $58 on October 25, 2022. Wells Fargo initiated its recommendation with a Overweight and recommended $49 as its price target on September 02, 2022. KeyBanc Capital Markets started tracking with a Overweight rating for this stock on July 15, 2022, and assigned it a price target of $47. In a note dated June 23, 2022, B. Riley Securities initiated an Buy rating and provided a target price of $53 on this stock.
This stock has fluctuated between a low of $24.83 and a high of $85.81 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $73 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $91.00 at the most recent close of the market. An investor can expect a potential drop of -19.78% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
Trailing Twelve Months sales for Procept BioRobotics Corp [NASDAQ:PRCT] were 199.84M which represents 66.29% growth. Gross Profit Margin for this corporation currently stands at 0.53% with Operating Profit Margin at -0.62%, Pretax Profit Margin comes in at -0.59%, and Net Profit Margin reading is -0.59%. To continue investigating profitability, this company’s Return on Assets is posted at -0.28, Equity is -0.38 and Total Capital is -0.33. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 86.29 points at the first support level, and at 81.57 for the second support level. However, for the 1st resistance point, the stock is sitting at 93.48, and for the 2nd resistance point, it is at 95.95.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Procept BioRobotics Corp [NASDAQ:PRCT] is 6.02. On the other hand, the Quick Ratio is 5.07, and the Cash Ratio is 5.0. Considering the valuation of this stock, the price to sales ratio is 23.65, the price to book ratio is 18.76.
Transactions by insiders
Recent insider trading involved Waters Kevin, EVP, CFO, that happened on Oct 15 ’24 when 25000.0 shares were sold. EVP, CFO, Waters Kevin completed a deal on Sep 16 ’24 to sell 25000.0 shares. Meanwhile, Affiliate Kevin Waters bought 50000.0 shares on Sep 16 ’24.
